The Lancet Neurology: Post-concussion 'Return to Play' Decision for Footballers Should Be Made Solely by Doctors, Says New Editorial
Published: July 13, 2014.
Released by The Lancet
An editorial published today in The Lancet Neurology calls for sports authorities to take into consideration the long term neurological problems that repeated concussions can cause. Cerebral concussion is the most common form of sports-related traumatic brain injury (TBI), and the long-term effects of repeated concussions may include dementia, amyotrophic lateral sclerosis, and other neurological disorders, say the journal editors.
Full Story »
More news from The Lancet
The Lancet: from Hiroshima And Nagasaki to Fukushima - Series Highlights Long-term Psychological Impact of Nuclear Disasters
On the 70th anniversary of the atomic bombs in Hiroshima and Nagasaki, a three-part Series published in The Lancet looks at the enduring radiological and psychological impact of nuclear disasters, including the most recent accident at the Fukushima Daiichi nuclear power plant in Japan in 2011. The Series provides vital information for the public health planning of future disasters to protect the millions of people who live in areas surrounding the 437 nuclear power plants that are in operation worldwide.
The Lancet: New Studies Show That 2 Classes of Inexpensive Generic Drugs Can Reduce Breast Cancer Deaths
Two new studies, both published in The Lancet, suggest that two different classes of drugs, aromatase inhibitors (AIs) and bisphosphonates, can each improve survival prospects for postmenopausal women with early breast cancer. Moreover, the researchers suggest that the two types of drug can be used together, increasing the benefits while also decreasing some side-effects.
The Lancet: Study Reveals Dramatic Shortfall in Donor Funding for Key Global Health Issues
As the world's leaders gather in Addis Ababa, Ethiopia, for the Financing for Development Conference , a study published in The Lancet demonstrates that a new approach is needed for classifying funding that reflects the function the funding serves, rather than the specific disease or country. The study is the first in-depth assessment of how donor funding is spent on global versus country-specific functions of health .
The Lancet Respiratory Medicine: First Trial of Gene Therapy for Cystic Fibrosis to Show Beneficial Effect on Lung Function
For the first time gene therapy for cystic fibrosis has shown a significant benefit in lung function compared with placebo, in a phase 2 randomised trial published in The Lancet Respiratory Medicine journal. The technique replaces the defective gene response for cystic fibrosis by using inhaled molecules of DNA to deliver a normal working copy of the gene to lung cells.
The Lancet Global Health: Increasing Secondary Education Protects Against HIV Infection
Longer secondary schooling substantially reduces the risk of contracting HIV, particularly for girls, according to new research from Botswana published in The Lancet Global Health journal. The researchers estimate that pupils who stayed in school for an extra year of secondary school had an 8 percentage point lower risk of HIV infection about a decade later, from about 25% to about 17% infected.
The Lancet: New Rapid Diagnostic Test for Ebola Could Be Game Changer in the Fight Against the Disease
A new test can accurately predict within minutes if an individual has Ebola Virus Disease (EVD), according to new research published in The Lancet. The study is the first to show that a point-of-care EVD test (ReEBOV Antigen Rapid Test; Corgenix) is faster than and as sensitive as a conventional laboratory-based molecular method used for clinical testing during the recent outbreak in Sierra Leone.
UNAIDS-Lancet Commission: World Must Drastically Accelerate AIDS Efforts Or Face More
Countries most affected by HIV must focus on stopping new HIV infections and expanding access to antiretroviral treatment or risk the epidemic rebounding, urges a major new report from the UNAIDS and Lancet Commission.
The Lancet: over 95% of the World's Population Has Health Problems - with over a Third Having More Than 5 Ailments
Just one in 20 people worldwide (4·3%) had no health problems in 2013, with a third of the world's population (2·3 billion individuals) experiencing more than five ailments, according to a major new analysis from the Global Burden of Disease Study (GBD) 2013, published in The Lancet.